AlvinaDChuMD
Rheumatology • Palo Alto, CAProfessor, Medicine - Oncology, Stanford University Medical Center
Dr. Chu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Welch Rd
Ste 203
Palo Alto, CA 94304Phone+1 650-723-6961Fax+1 650-725-8418
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Rheumatology, 2005 - 2007
University of ChicagoResidency, Internal Medicine, 2002 - 2005
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2002
Certifications & Licensure
CA State Medical License 2004 - 2026
IL State Medical License 2002 - 2005- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 139 citationsSafety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results fr...Kristian Reich, Henrique D. Teixeira, Marjolein S. de Bruin-Weller, Thomas Bieber, Weily Soong
Lancet. 2021-06-05 - 36 citationsUpadacitinib in Active Ankylosing Spondylitis: 1-Year Results From the Double-Blind, Placebo-Controlled SELECT-AXIS 1 Study and Open-Label ExtensionAtul Deodhar, Désirée van der Heijde, Joachim Sieper, Filip Van den Bosch, Walter P. Maksymowych
Arthritis & Rheumatology. 2021-07-01 - 181 citationsEfficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase ...Désirée van der Heijde, In-Ho Song, Aileen L. Pangan, Atul Deodhar, Filip Van den Bosch
Lancet. 2019-12-07
Journal Articles
- Evaluation of 230 Patients with relapsed/refractory Deletion 17p Chronic Lymphocytic Leukaemia Treated with Ibrutinib from 3 Clinical TrialsSteven Coutre, Richard R Furman, William G Wierda, Nyla A Heerema, Alvina D Chu, Jeffrey Jones, John C Byrd, British Journal of Haematology
Press Mentions
Orange County Officials to Give Update on COVID-19 ThursdayAugust 26th, 2021- Multisystem Inflammatory Syndrome, Pneumonia Concern Doctors as About 45 Central Florida Kids Are Hospitalized with COVIDAugust 25th, 2021
- Herd Immunity ‘Practically Impossible’ in Orange County at This Point, Health Experts SayAugust 24th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
